Topcon Healthcare
VC Fund
Oakland, United States
Topcon Healthcare is a VC fund in Oakland focused on Health Care and Software. Topcon Healthcare solutions provide imaging, diagnostic solutions, and intelligent data technology. They specialize in developing optical, sensing, and control solutions with digital transformation technologies for industries. Their solutions include multimodal imaging, vendor-neutral data management, and groundbreaking remote diagnostictechnology.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Topcon Healthcare invests in
Stages Topcon Healthcare invests in
Countries Topcon Healthcare invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Series A
- $6.2M–$10M
Investment Focus
Industry
- Health Care 7 (78%)
- Software 4 (44%)
- Medical Device 3 (33%)
- Health Diagnostics 3 (33%)
- Machine Learning 2 (22%)
Stage
- Series A 3 (33%)
- Corporate Round 3 (33%)
- Seed 1 (11%)
- Series B 1 (11%)
- Venture - Series Unknown 1 (11%)
Country
- Switzerland 2 (22%)
- United States 2 (22%)
- United Kingdom 2 (22%)
- Canada 1 (11%)
- New Zealand 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Anssi Ylimaula
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
Jacqueline Ferro
Global Vice President Regulatory & Quality Assurance
|
Global Vice President Regulatory & Quality Assurance | Total investments: 0 | Find email | |
Lance Patton
CCO
|
CCO | Total investments: 1 | Find email | |
Ville Wuotila
Vice President Of Products, Global
|
Vice President Of Products, Global | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Senseye
|
Senseye was created to shape the future of computing. Here at Senseye, it is our core mission to bring the most intelligent and creative minds together in order to shape our aspirations for the future. Our goal is to create an emotional resonance between humans and computers that mirrors the intimate resonance that exists between people.Foundedwith the vision of shaping the future of computing, and that is exactly what we are doing. We have always been inspired by the words President John F. Kennedy spoke in September 1962, when he announced that the United States would seek to send a man to the moon. In the spirit of exploring new worlds, our company’s purpose is to work on “moonshots” much like the bold, inspiring goal to land a man on the moon, set more than 50 years ago. A “moonshot” is defined as a project that addresses an enormous problem, proposes a radical solution and uses breakthrough technology.Senseye uses novel non-invasive measurements of ocular physiology to quantify patterns of cognitive ability, human performance, health and psychological wellbeing including vital signs, attention and recognition/cognitive load, and fatigue and impairment. As we progress the technology we will increasingly focus on emotional responses and mental health condition for diagnosis. Senseye delivers previously unavailable cognitive & health insights via standard camera equipment. | Corporate Round / Sep 09, 2025 | |
Bioxytech Retina
|
Bioxytech Retina provides the research of optical device to diagnose diabetes, using non-invasive imaging technology. It was founded in 2015 and is based in Richmond, California. | Corporate Round / Aug 26, 2025 | |
OKKO Health
|
Digital Health SAAS Smartphone Eye Health Monitoring | Seed / Jul 21, 2025 | |
Pangaea Data
|
Pangaea Data provides a machine learning-based software solution making scientific and clinical data more meaningful. | Corporate Round / May 27, 2025 | |
machineMD
|
machineMD is a medical device company, headquartered in Switzerland, with a subsidiary in Boston, USA, that is innovating at the intersection of neuroscience and ophthalmology.The company’s mission is to radically improve the measurement of brain function, with a vision for a world where people receive an accurate, fast, and early diagnosis ofbrain disorders. Together with a global network of clinical and research partners, our goal is to bring the diagnostic quality of highly trained tertiary care specialists where it is needed most, in primary and secondary care. | Venture - Series Unknown / Mar 18, 2025 | |
Retinai
|
RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietarytechnology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce. | $7.8M / Series B / Oct 16, 2024 | |
RetiSpec
|
RetiSpec is developing a non-invasive eye scanner for early detection of Alzheimer’s Disease pathology years before symptoms occur, so that clinicians can intervene with emerging therapeutics early, when there’s a chance of actually impacting the disease. | $10M / Series A / Jul 26, 2024 | |
|
Retinai
|
RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietarytechnology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce. | $6.2M / Series A / May 02, 2024 | |
Toku Eyes
|
Toku Eyes creates diagnostic and screening tools to eliminate doctors' preventable health and vision deterioration. The company's tools provide a collection of artificial intelligence engines, each specialized in using a different imaging modality for diagnostics, prognostics, or health assessment purposes, allowing clinicians to aid inthe prevention of diabetes and preventable blindness. | $8M / Series A / Apr 17, 2023 |
Co-Investors
Verve Ventures
2 deals together
Zürcher Kantonal Bank
2 deals together
Alzheimer's Drug Discovery Foundation
1 deal together
b2venture
1 deal together
Center of Aging and Brain Health Innovation
1 deal together
Eli Lilly
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Topcon Healthcare invest in?
Topcon Healthcare invests primarily in Health Care, Software and Medical Device startups, most often at Series A and Corporate Round stage. Most of the 9 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Topcon Healthcare's check size?
Topcon Healthcare typically joins rounds of $6.2M–$10M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Topcon Healthcare participates in.
How do I contact Topcon Healthcare?
Public channels for Topcon Healthcare include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Topcon Healthcare?
The team at Topcon Healthcare includes Anssi Ylimaula (Managing Director), Jacqueline Ferro (Global Vice President Regulatory & Quality Assurance) and Lance Patton (CCO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
